Ronald Davidson, a researcher at the U.S. Department of Energy's Princeton Plasma Physics Laboratory, has been selected to receive the Particle Accelerator Science and Technology Award for 2005. He will be honored on May 18 during the biennial Particle Accelerator Conference in Knoxville, Tenn.
The award, which recognizes Davidson for his important contributions to beam physics, is sponsored by a committee of the Institute of Electrical and Electronics Engineers Nuclear and Plasma Sciences Society. It includes a plaque and $2,000.
Davidson is deputy head of the theory department and head of the beam dynamics and nonneutral plasma division at the PPPL. He also is a professor of astrophysical sciences at Princeton and the deputy director of the Virtual National Laboratory for Heavy Ion Fusion, a collaborative effort between the PPPL, Lawrence Berkeley National Laboratory and Lawrence Livermore National Laboratory.
He earned his Ph.D. in plasma physics from Princeton in 1966 and joined the PPPL in 1991, serving as director of the lab until 1997.
Related stories:
Thomas Roser Wins 2005 Particle Accelerator Science and Technology Award
Thomas Roser, Associate Chair for Accelerators and Accelerator Division Head at the U.S. Department of Energy’s Brookhaven National Laboratory, has been selected as one of two recipients of the 2005 Particle Accelerator Science and Technology Award from the Nuclear and Plasma Science Society of the Institute of Electrical and Electronics Engineers, Inc. The award, which consists of a plaque and $2,000 for each recipient, will be given to Roser and to Ronald Davidson of Princeton University, on May 18, at the biennial particle accelerator conference to be held in Knoxville, Tennessee.
Protein complementarity may offer new insights into autoimmune diseases
The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused by anti-neutrophil cytoplasmic autoantibodies (ANCAs) may lead to new approaches to research, testing, and treatment of ANCA vasculitis and other autoimmune diseases, suggests a paper in the December
Journal of the American Society of Nephrology (
JASN).
Vitamin C injections slow tumor growth in mice
High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National Institutes of Health (NIH) report in the August 5, 2008, issue of the
Proceedings of the National Academy of Sciences. The researchers traced ascorbate's anti-cancer effect to the formation of hydrogen peroxide in the extracellular fluid surrounding the tumors. Normal cells were unaffected.
No longer splitting hairs over splitting atoms?
As public opinion shifts and many more governments around the world consider nuclear energy as a solution to climate concerns and energy security, it is time to ask why it has become a more attractive option. The Institute of Physics (IOP) ran two sessions at this year’s Euroscience Open Forum (ESOF 2008) to hold a public discussion about the future for both nuclear fission and fusion as sources of electricity.
NSF awards grant to track 'space weather' in Earth's near-space environment
Global and real-time "space weather" observations of near-Earth space--and the solar storms that can knock out electric power grids--is about to happen for the first time, thanks to funding from the National Science Foundation (NSF).
HIV conquers immune system faster than previously realized
New research into the earliest events occurring immediately upon infection with HIV-I shows that the virus deals a stunning blow to the immune system earlier than was previously understood. According to scientists at Duke University Medical Center, this suggests the window of opportunity for successful intervention may be only a matter of days – not weeks – after transmission, as researchers had previously believed.
HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study
In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for preventing the virus.
New insight to demineralization
From toothpaste to technology, noncrystalline or amorphous silica is an active ingredient in a myriad of products that we use in our daily lives. As a minor, but essential component of vertebrate bone, an understanding of silica reactivity in physiological environments is crucial to the development of successful biomedical implants and synthetic materials with bone-like properties.